The agreement with Palatin follows a $1bn deal with Re-Vana earlier this year as Boehringer targets the ophthalmology market.

Ever since taking his seat as Secretary of the U.S. Health and Human Services (HHS) under a banner of “radical transparency,” ...

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

Nivin Pauly’s web series debut, which is helmed by PR Arun, is all set to begin streaming on JioHotstar. The series also has ...

India seeks to significantly boost its medicine exports to Mexico, a market currently valued at over $20 billion and expected ...

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...

An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the ...

Every aspect of science and research is based on data, and across the globe, labs are producing more data than the average ...

An experimental Pfizer sickle cell treatment failed to meet the main goal in a late-stage trial for patients aged 16 and ...

The partnership grants Envirotainer exclusive global rights to offer the innovative Swiss Airtainer as part of its full ...

Over the past decade, AbbVie's shares have increased by 353.3%, or 16.3% annually, with dividends reinvested. That's ...

Hikal Ltd. VP discusses India's rise in pharmaceutical contract manufacturing, projecting significant growth in global market ...